home / stock / femy / femy articles

FEMY Articles, Femasys Inc.

Stock Information
Company Name: Femasys Inc.
Stock Symbol: FEMY
Market: NASDAQ
Website: femasys.com
Menu
FEMY FEMY Quote FEMY Short FEMY News FEMY Articles FEMY Message Board
Get FEMY Alerts

News, Short Squeeze, Breakout and More Instantly...
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in Amsterdam | Benzinga

ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet ne...
Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining more than 300 points on Thursday. The Dow traded up 0.87% to 3...

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...

Gold Rises 1%; Accenture Shares Surge After Q3 Results | Benzinga

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 50 points on Thursday. Following the market opening Thursd...
EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says | Benzinga

Femasys Inc (NASDAQ:FEMY) is a biomedical company focused on women’s healthcare. The company, with a market capitalization of $22.50 million ...

Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape | Benzinga

ATLANTA, March 21, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical company focused on addressing the significant unme...

Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024 | Benzinga

-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment...
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer | Benzinga

-- Seasoned sales and marketing executive with 25 years of experience leading public and private healthcare companies throughout various stages of...

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer | Benzinga

ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a biomedical company focused on meeting significant unmet needs for women...

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech | Benzinga

- $6.85 million upfront investment provides $23 million total cash runway into second half 2025 - - Financing allows for focused commercial team t...
Next 10